The prognostic significance of apoptosis-related biological markers in chinese gastric cancer patients

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Liu, Xiaowen ^a,b   Cai, Hong ^a,b   Huang, Hua ^a,b   Long, Ziwen ^a,b   Shi, Yingqiang ^a,b   Wang, Yanong ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CHINA; CHINESE; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION; UNIVERSITY HOSPITAL; APOPTOSIS; BLOOD; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

APOPTOSIS; CHINA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84555191381     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029670     Document Type: Article

References (37)

1. Shibata A, Parsonnet J, (2006) Stomach cancer. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention, 3rd edn New York Oxford University Press pp. 707-720.
2. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
3. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM, (2002) Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 95: 1434-1443.
4. Lerut T, Coosemans W, Decker G, De Leyn P, Ectors N, et al. (2003) Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 126: 1121-1128.
5. Liu X, Xu Y, Long Z, Zhu H, Wang Y, (2009) Prognostic significance of tumor size in T3 gastric cancer. Ann Surg Oncol 16: 1875-1882.
6. Lee KE, Lee HJ, Kim YH, Yu HJ, Yang HK, et al. (2003) Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol 33: 173-179.
7. Al Moundhri MS, Nirmala V, Al Hadabi I, Al Mawaly K, Burney I, et al. (2005) The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. J Surg Oncol 91: 243-252.
8. Okuyama T, Maehara Y, Kabashima A, Takahashi I, Kakeji Y, et al. (2002) Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma. Oncology 63: 353-361.
9. Lee HK, Lee HS, Yang HK, Kim WH, Lee KU, et al. (2003) Prognostic significance of Bcl-2 and p53 expression in gastric cancer. Int J Colorectal Dis 18: 518-525.
10. Bartchewsky W Jr, Martini MR, Squassoni AC, Alvarez MC, Ladeira MS, et al. (2010) Effects of Helicobacter pylori infection on the expressions of Bax and Bcl-2 in patients with chronic gastritis and gastric cancer. Dig Dis Sci 55: 111-116.
11. Galizia G, Ferraraccio F, Lieto E, Orditura M, Castellano P, et al. (2006) p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate. J Surg Oncol 93: 241-252.
12. Fenoglio Preiser CM, Wang J, Stemmermann GN, Noffsinger A, (2003) TP53 and gastric carcinoma: a review. Hum Mutat 21: 258-270.
13. Wiksten JP, Lundin J, Nordling S, Kokkola A, von Boquslawski K, et al. (2002) The prognostic value of p27 in gastric cancer. Oncology 63: 180-184.
14. Kroemer G, (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3: 614-620.
15. Maeda S, Yoshida H, Mitsuno Y, Hirata Y, Oqura K, et al. (2002) Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Mol Pathol 55: 286-293.
16. Zhang H, Fang DC, Wang RQ, Yang SM, Liu HF, et al. (2004) Effect of Helicobacter pylori infection on expression of Bcl-2 family members in gastric adenocarcinoma. World J Gastroenterol 10: 227-230.
17. Adachi Y, Mori M, Maehara Y, Suqimachi K, (1994) Dukes's classification: a valid prognostic indicator for gastric cancer. Gut 35: 1368-1371.
18. Maruyama K, (1987) The most important prognostic factors for gastric cancer patients: a study using univariate and multivariate analyses. Scand J Gastroenterol 22: 63-68.
19. Chau I, Morman AR, Cunningham D, Waters JS, Oates J, et al. (2004) Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer - pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 22: 2359-2403.
20. Yokota T, Ishiyama S, Saito T, Teshima S, Narushima Y, et al. (2004) Lymph node metastasis as a significant prognostic factor in gastric cancer: A multiple logistic regression analysis. Scand J Gastroenterol 39: 380-384.
21. Dicken BJ, Saunders LD, Jhangri GS, de Gara C, Cass C, et al. (2004) Gastric cancer: Establishing predictors of biologic behaviour with use of population-based data. Ann Surg Oncol 11: 629-635.
22. Ye YW, Fu H, Zhou Y, Du CY, Li BZ, et al. (2009) Study on the different Expression of Molecular Markers between Cardiac Cancer and Distal Gastric Cancer and Their Correlations with Clinicopathological Features. Dig Surg 26 (5): 384-391.
23. Tsamandas AC, Kardamakis D, Tsiamalos P, Liava A, Tzelepi V, et al. (2009) The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome. Anticancer Res 29: 703-709.
24. Anaqnostopoulos GK, Stefanou D, Arkoumani E, Chalkley L, Karagiannis J, et al. (2007) Expression of Bax protein in gastric carcinomas. A clinicopathological and immunohistochemical study. Acta Gastroenterol Belg 70: 285-289.
25. Lee DS, Kang SB, Baek JT, Nam SW, Lee KM, et al. (2005) Immunohistochemical expression of bcl-2, bcl-xl, bax, p53 proteins in gastric adenoma and adenocarcinoma. Korean J Gastroenterol 45: 394-400.
26. Ninomiya I, Yonemura Y, Matsumoto H, Suqiyama K, Kamata T, et al. (1991) Expression of c-myc gene product in gastric carcinoma. Oncology 48: 149-153.
27. Maehara Y, Okuyama T, Kakeji Y, Endo K, Yamamoto M, et al. (1995) A tumor-associated cell-surface glycoprotein accompanying p53 over-expression and higher growth potential for gastric cancer. Br J Cancer 71: 999-1002.
28. Maehara Y, Tomoda M, Hasuda S, Kabashima A, Tokunaga E, et al. (1999) Prognostic value of p53 protein expression for patients with gastric cancer-multivariate analysis. Br J Cancer 79: 1255-1261.
29. Motojima K, Furui J, Kohara N, Ito T, Kanematsu T, (1994) Expression of p53 protein in gastric carcinomas is not independently prognostic. Surgery 116: 890-895.
30. Gabbert HE, Muller W, Schneiders A, Meier S, Hommel G, (1995) The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 76: 720-726.
31. Krajewski S, Krajewska M, Shabik A, Miyashita T, Wang HG, et al. (1994) Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am J Pathol 145: 1323-1336.
32. Korsmeyer S, (1992) Bcl-2 initiates a new category of oncogene: regulators of cell death. Blood 80: 879-886.
33. Saegusa M, Takano Y, Okayasu I, (1995) Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia. J Cancer Res Clin Oncol 121: 357-363.
34. Nakanishi H, Ohsawa M, Naka N, Uchida A, Ochi T, et al. (1997) Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlations with prognosis. Oncology 54: 238-244.
35. Ishida H, Irie K, Itoh T, Furukawa T, Tokunaga O, (1997) The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. Cancer 80: 1034-1045.
36. Aizawa K, Ueki K, Suzuki S, Yabusaki H, Kanda T, et al. (1999) Apoptosis and Bcl-2 expression in gastric carcinoma: correlation with clinicopathological variables, p53 expression, cell proliferation and prognosis. Int J Oncol 14: 85-91.
37. Pietenpol JA, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW, et al. (1994) Paradoxical inhibition of solid tumor cell growth by bcl-2. Cancer Res 54: 3714-3717.